Be sure to take the recommended dose and consult with your doctor, especially if you plan to take high doses
In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2-hour postprandial glucose, and 30 mg/dL (22%) for mean 24-hour glucose concentration (see Figure 1)
[...] FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products
Narum, S., Westergren, T., & Klemp, M